1 most recent filing and news item mentioning MBRN. Updated every 60 seconds.
RegulatoryJun 30, 2026Neutral
Moleculin Biotech has filed an exhibit with the SEC, usually containing supplementary information such as a press release. Investors should review this document for specific corporate updates.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.